Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation

Journal of Clinical Investigation

Volumn 124, Issue 1, 2014, Pages 297-310

  Xiu, Yan ^a   Xu, Hao ^a   Zhao, Chen ^a   Li, Jinbo ^a   Morita, Yoshikazu ^a   Yao, Zhenqiang ^a   Xing, Lianping ^a   Boyce, Brendan F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHLOROQUINE; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BINDING AFFINITY; CELL ACTIVATION; CELL LINEAGE; COMPARATIVE STUDY; CONTROLLED STUDY; DELETION MUTANT; FEMALE; LYSOSOME; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RING FINGER MOTIF; SIGNAL TRANSDUCTION; STROMA CELL; TRABECULAR BONE; UBIQUITINATION;

EID: 84892919504     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66947     Document Type: Article

References (71)

1. Sitara D, Aliprantis AO. Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev. 2010;233(1):286-300
2. Teitelbaum SL. Osteoclasts. What do they do and how do they do it? Am J Pathol. 2007;170(2):427-435
3. Braun T, Zwerina J. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther. 2011;13(4):235
4. Boyce BF. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res. 2013;28(4):711-722
5. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-êB signaling pathways. Nat Immunol. 2011;12(8):695-708
6. Franzoso G, et al. Requirement for NF-êB in osteoclast and B-cell development. Genes Dev. 1997; 11(24):3482-3496
7. Iotsova V, et al. Osteopetrosis in mice lacking NF-êB1 and NF-êB2. Nat Med. 1997;3(11):1285-1289
8. Vaira S, et al. RelB is the NF-êB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A. 2008;105(10):3897-3902
9. Yao Z, Xing L, Boyce BF. NF-êB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest. 2009; 119(10):3024-3034
10. Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB. TNFinduced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med. 2012;209(2):319-334
11. Yang C, et al. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One. 2010;5(11):e15383
12. Hacker H, Tseng PH, Karin M. Expanding TRAF function. TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011;11(7):457-468
13. Bishop GA. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat Rev Immunol. 2004; 4(10):775-786
14. Rothe M, Sarma V, Dixit VM, Goeddel DV. TRAF2- mediated activation of NF-êB by TNF receptor 2 and CD40. Science. 1995;269(5229):1424-1427
15. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature. 1996;383(6599):443-446
16. Xu Y, Cheng G, Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 1996; 5(5):407-415
17. Liao G, Zhang M, Harhaj EW, Sun SC. Regulation of the NF-êB-inducing kinase by tumor necrosis factor receptor-Associated factor 3-induced degradation. J Biol Chem. 2004;279(25):26243-26250
18. He JQ, et al. Rescue of TRAF3-null mice by p100 NF-êB deficiency. J Exp Med. 2006;203(11):2413-2418
19. Novack DV, et al. The IêB function of NF-êB2 p100 controls stimulated osteoclastogenesis. J Exp Med. 2003;198(5):771-781
20. Li P, et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor á-transgenic mice. Arthritis Rheum. 2004;50(1):265-276
21. Cheng G, et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 1995; 267(5203):1494-1498
22. He JQ, Saha SK, Kang JR, Zarnegar B, Cheng G. Specificity of TRAF3 in its negative regulation of the noncanonical NF-êB pathway. J Biol Chem. 2007; 282(6):3688-3694
23. Dadgostar H, Cheng G. An intact zinc ring finger is required for tumor necrosis factor receptor-Associated factor-mediated nuclear factor-êB activation but is dispensable for c-Jun N-terminal kinase signaling. J Biol Chem. 1998;273(38):24775-24780
24. Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861-2873
25. Vallabhapurapu S, et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-êB signaling. Nat Immunol. 2008;9(12):1364-1370
26. Clague MJ, Urbe S. Ubiquitin. same molecule, different degradation pathways. Cell. 2010; 143(5):682-685
27. Ang E, et al. Proteasome inhibitors impair RANKLinduced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IêBá signaling cascades. J Cell Physiol. 2009;220(2):450-459
28. Yamamoto A, et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct. 1998;23(1):33-42
29. Wu YT, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010; 285(14):10850-10861
30. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine. From malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42(2):145-153
31. Tam CS, Heersche JN, Murray TM, Parsons JA. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action. differential effects of intermittent and continuous administration. Endocrinology. 1982;110(2):506-512
32. Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992;7(1):65-72
33. Ma YL, et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-Associated bone formation. Endocrinology. 2001;142(9):4047-4054
34. Yates AJ, et al. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J Clin Invest. 1988;81(3):932-938
35. Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4(2):151-175
36. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27-42
37. Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol. 2009;29(10):2594- 2608
38. Tseng PH, et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol. 2010;11(1):70-75
39. Zarnegar B, Yamazaki S, He JQ, Cheng G. Control of canonical NF-êB activation through the NIKIKK complex pathway. Proc Natl Acad Sci U S A. 2008; 105(9):3503-3508
40. Bista P, et al. TRAF3 controls activation of the canonical and alternative NFêB by the lymphotoxin beta receptor. J Biol Chem. 2010;285(17):12971-12978
41. Simonet WS, et al. Osteoprotegerin. A novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309-319
42. Kukita T, et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004; 200(7):941-946
43. Senftleben U, et al. Activation by IKKá of a second, evolutionary conserved, NF-êB signaling pathway. Science. 2001;293(5534):1495-1499
44. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IêB kinase complex (IKK) contains two kinase subunits, IKKá and IKKâ, necessary for IêB phosphorylation and NF-êB activation. Cell. 1997;91(2):243-252
45. Takayanagi H, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-Â. Nature. 2002;416(6882):744-749
46. Vaira S, et al. RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest. 2008; 118(6):2088-2097
47. Deretic V, Jiang S, Dupont N. Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 2012;22(8):397-406
48. Zhang L, et al. Pathway-based genome-wide association analysis identified the importance of regulation- of-Autophagy pathway for ultradistal radius BMD. J Bone Miner Res. 2010;25(7):1572-1580
49. DeSelm CJ, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell. 2011;21(5):966-974
50. Ganeff C, et al. Induction of the alternative NF-êB pathway by lymphotoxin áâ (LTáâ) relies on internalization of LTâ receptor. Mol Cell Biol. 2011; 31(21):4319-4334
51. Nakhaei P, et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 2009;5(11):e1000650
52. Zarnegar BJ, et al. Noncanonical NF-êB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol. 2008; 9(12):1371-1378
53. Djavaheri-Mergny M, et al. NF-êB activation represses tumor necrosis factor-Á-induced autophagy. J Biol Chem. 2006;281(41):30373- 30382
54. Criollo A, et al. Autophagy is required for the activation of NFêB. Cell Cycle. 2012;11(1):194-199
55. Criollo A, et al. The IKK complex contributes to the induction of autophagy. EMBO J. 2010; 29(3):619-631
56. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-êB as the matchmaker. Nat Immunol. 2011; 12(8):715-723
57. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861-1874
58. Davila L, Ranganathan P. Pharmacogenetics. implications for therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7(9):537-550
59. Lee CK, et al. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor êB, osteoprotegerin, and receptor activator of nuclear factor êB ligand. Arthritis Rheum. 2004;50(12):3831-3843
60. Voronov I, et al. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation and decreases in vitro osteoclastogenesis. J Bone Miner Res. 2013; 28(1):108-118
61. Kimura T, Takabatake Y, Takahashi A, Isaka Y. Chloroquine in cancer therapy. A double-edged sword of autophagy. Cancer Res. 2013;73(1):3-7
62. Lotze MT, Maranchie J, Appleman L. Inhibiting autophagy. A novel approach for the treatment of renal cell carcinoma. Cancer J. 2013;19(4):341-347
63. Keats JJ, et al. Promiscuous mutations activate the noncanonical NF-êB pathway in multiple myeloma. Cancer Cell. 2007;12(2):131-144
64. Xiao Y, et al. Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nat Med. 2013;19(5):595-602
65. Burkly L, et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995;373(6514):531-536
66. Gardam S, Sierro F, Basten A, Mackay F, Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity. 2008;28(3):391-401
67. Zhang Q, et al. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem. 2008; 283(19):13491-13499
68. Parkhitko A, et al. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci U S A. 2011;108(30):12455-12460
69. Calvi LM, et al. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood. 2012;119(11):2489-2499
70. Schwarz EM, et al. Tumor necrosis factor-Á/nuclear transcription factor-êB signaling in periprosthetic osteolysis. J Orthop Res. 2000;18(3):472-480
71. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. Histone H3 phosphorylation by IKK-Á is critical for cytokine-induced gene expression. Nature. 2003;423(6940):655-659.